Session Information
2013 Midyear Clinical Meeting
Click here to go to the previous page
340B Drug Pricing Program Update
Track:
Education Sessions (CE)
Program Code: 241-L04
Date: Monday, December 9, 2013
Time: 2:00 PM to 4:00 PM EST
Location:
W202 C, Level 2
PRESENTER(S):
Patrick Barnes
Mr. Christopher Hatwig, M.S., R.Ph., President, 340B Prime Vendor Program, Apexus
marcy imada
George Kenny
Sarah Lee
Krista Pedley, LCDR, USPHS
PROGRAM CHAIR:
Mr. Christopher Hatwig, M.S., R.Ph., President, 340B Prime Vendor Program, Apexus
- Describe current 340B policy topics, including the GPO Prohibition and the Orphan Drug Exclusion.
- Discuss tools available to self-assess in preparation for an audit.
- Explain the key points of the HRSA and manufacturer audit processes.
No items are available for this session.